Your session is about to expire
← Back to Search
Anti-smoking Interventions for Cigarette Smoking (RESIST Trial)
RESIST Trial Summary
This trial is testing whether culturally tailored messages can help young queer women resist smoking.
RESIST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RESIST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are attracted to people of the opposite gender.You are a female.You identify as a sexual orientation other than heterosexual.Male participants. (Note: This criterion alone does not provide enough information to determine exclusion criteria.)
- Group 1: Culturally Tailored (Smokers)
- Group 2: Culturally tailored (Non-smokers)
- Group 3: Non-culturally tailored (Non-smokers)
- Group 4: Non-culturally Tailored (Smokers)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment allow minors to participate?
"This study has an age restriction of 18-30 years old."
What types of individuals are ideal for enrollment in this medical experiment?
"The current medical trial is seeking 2,214 individuals who use tobacco tar and range in age from 18 to 30 years old. Particularly, the participants must be female and identify as a sexual minority (any orientation other than heterosexual)."
Is enrollment in this scientific experiment still accessible to potential participants?
"According to the clinicaltrials.gov website, no new patients are being recruited for this trial at present moment; however, it was initially published on September 8th 2021 and last updated on June 28th 2022. Alternately, two other trials can be pursued by potential participants right now."
Share this study with friends
Copy Link
Messenger